NRC Health announced its first quarter 2023 results, with a focus on personalized care and expanding sales and marketing resources. The company funded innovation and growth, dividend payments, and share repurchases during the quarter. Diluted earnings per share decreased compared to the same period last year.
Focused on enabling healthcare organizations to deliver personalized care.
Expanding sales and marketing resources to increase awareness and adoption of the Human Understanding Program.
Board of Directors maintained capital allocation priorities of funding innovation and growth investments, shareholder dividends and share repurchases.
Diluted earnings per share decreased to $0.28 for the quarter ended March 31, 2023, from diluted earnings per share of $0.34 for the quarter ended March 31, 2022.
No specific forward guidance provided in the press release.
Analyze how earnings announcements historically affect stock price performance